NCT06848374View on ClinicalTrials.gov

Dose Efficacy in Adhesive Capsulitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Adhesive Capsulitis of the Shoulder
Interventions
DRUG

40 mg Methylprednisolone

Ultrasound guided injection of 40mg methylprednisolone injection

DRUG

80 mg Methylprednisolone

Ultrasound guided injection of 40mg methylprednisolone injection

Trial Locations (1)

M9C 2X8

RECRUITING

Toronto Rehabilitation Institution, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER